浆液性囊腺癌

  • 网络serous cystadenocarcinoma
浆液性囊腺癌浆液性囊腺癌
  1. PPARγ在卵巢浆液性囊腺癌中的表达

    Expression of PPAR γ in ovarian serous cystadenocarcinoma

  2. 结果:浆液性囊腺癌11例,交界性浆液性囊腺瘤1例,粘液性囊腺癌2例,交界性粘液性囊腺瘤2例,颗粒细胞瘤2例,恶性畸胎瘤2例。

    Results : Of 20 cases of primary malignant ovarian neoplasms , there were 11 cases of serous cystadenocarcinoma , 1 borderline serous cystadenoma , 2 mucous cystadenocarcinoma , 2 borderline mucous cystadenoma , 2 granulous cell tumor and 2 malignant teratoma .

  3. 短链烯酰辅酶A水合酶的mRNA在卵巢浆液性囊腺癌中的表达及其临床意义

    Expression and Clinical Significance of Short Chain Enoyl-coa Hydratase mRNA in Ovarian Serous Cystadenocarcinoma

  4. 卵巢浆液性囊腺癌细胞周期分布与突变p53蛋白表达的研究

    A Study on Distribution of Cell Cycle and Expression of Mutant p53 in Ovary Serous Adenocarcinoma

  5. 在卵巢浆液性囊腺癌,COX一2蛋白的表达水平与肿瘤临床病理参数无明显相关。

    There is no significant correlation between COX-2 expression and clinical pathologic parameters in ovarian serous cystadenocarcinoma .

  6. 浆液性囊腺癌中Cx43表达显著降低(p<0.01),而且随囊腺癌分化程度的下降,Cx43表达也显著降低(p<0.01)。

    Furthermore , the expression of CX43 was significantly reduced as cancel cells became morphologically less differentiated ( p < 0.01 ) .

  7. 目的研究卵巢浆液性囊腺癌细胞周期分布情况及突变p53蛋白的表达。

    Objective To study the distribution of cell cycle and expression of mutant p53 in ovary serous adenocarcinoma and their relations with histopathology .

  8. 人卵巢浆液性囊腺癌高低转移细胞株E-cadherin差异表达

    The Different Expression of E-cadherin in High and Low Metastatic Human Ovary Serous Cystadenocarcinoma Cell Strains

  9. 卵巢浆液性囊腺癌中pRb蛋白的表达及其临床意义

    Clinical values of pRb expression in human serous ovarian carcinoma

  10. 结果:卵巢浆液性囊腺癌和粘液性囊腺癌患者外周血中CD4+CD25+调节性T细胞数量均明显升高(P0.05);

    Results : The population of CD4 + CD25 + T cells in peripheral blood mononuclear cell from patients with serous cystadenocarcinoma , mucinous cystadenocarcinoma was significantly higher in comparison with that of controls .

  11. 人卵巢浆液性囊腺癌永生化细胞系BUPH∶OVCA-3的建立及其生物学特性

    Establishment and Characterization of an Immortalized Human Ovarian Serous Cystadenocarcinoma Cell Line BUPH ∶ OVCA-3

  12. Jagged-1蛋白在卵巢癌中的表达:Jagged-1蛋白在卵巢浆液性囊腺癌中表达在癌细胞的细胞浆和细胞核,在卵巢正常组织中阳性定位在部分颗粒细胞。

    The expression of Jagged-1 protein in ovarian cancer : Jagged-1 protein was expressed in cytoplasm and nucleus , and was positive in granular cell in normal tissue of ovary .

  13. 1例于术后7年继发双侧卵巢乳头状浆液性囊腺癌。

    One patient developed serous cystadenocarcinoma after 7 years of operation .

  14. 人卵巢浆液性囊腺癌侵袭转移与β-catenin相关性的实验研究

    The Study of Relationship between β - catenin and Invasion and Metastasis Potency of Serous Cystadenocarcinoma

  15. 缺氧诱导因子-1α与卵巢浆液性囊腺癌的相关性

    The study of relationship of hypoxia-inducible factor-1 α expression and clinicopathological features and proliferation in ovarian serous cystadenocarcinoma

  16. 方法采用流式细胞学和免疫组织化学方法对16例卵巢浆液性囊腺癌及4例正常卵巢组织进行了研究。

    Methods Use flow cytometry and immunohistochemistry method to study 16 cases ovary serous adenocarcinoma and 4 cases normal ovary tissue .

  17. 乳头状浆液性囊腺癌是由大量的实体组织构成,并已侵袭至卵巢外。表面可见乳头状突起。

    This ovarian papillary cystadenocarcinoma is mostly composed of solid tissue and has invaded outside of the ovary , with papillations seen over the surface .

  18. 本文随机将术后复发件恶性腹水的卯巢浆液性囊腺癌病人分成3组,1组给予常规全身化疗;

    The patients suffering from ovary serous cystadenocarcinoma with malignant ascites after surgical operation were divided into three groups randomly . The first group : the routine whole body chemotherapy was given by for patients ;

  19. 介绍人卵巢浆液性囊腺癌永生化细胞系的建立,研究其生物学特性.以卵巢浆液性乳头状囊腺癌的腹水细胞为材料,进行体外培养。

    To establish an immortalized human ovarian serous cystadenocarcinoma cell line , and study its biological characteristics , a specimen derived from ascites of a human ovarian serous papilliform cystadenocarcinoma was obtained and cultured in vitro .

  20. 卵巢浆液性乳头状囊腺癌中PTEN、survivin和MMP-2的表达及临床意义

    The Expression and Its Clinical Significance of PTEN , Survivin , and MMP-2 in Ovarian Serous Adenocarcinoma

  21. Genistein对人卵巢浆液性乳头状囊腺癌细胞系SKOV3体内和体外侵袭的抑制作用

    Inhibitory effect of genistein on invasion of human ovarian carcinoma cell line SKOV_3 in vivo and in vitro

  22. 结论:Genistein可明显抑制人卵巢浆液性乳头状囊腺癌细胞系SKOV3及其条件培养基对人内皮细胞系ECV-304细胞的诱导迁移作用;

    Up-regulate the expression of TGF β - 1 . Conclusion : Migrations of ECV-304 induced by human ovarian carcinoma cell line SKOV_3 or its conditioned media were apparently inhibited by Genistein .

  23. 目的:研究Genistein对人卵巢浆液性乳头状囊腺癌细胞系SKOV3诱导人内皮细胞系ECV-304迁移的作用,以探讨Genistein抑制血管生成作用的机理。

    Objective : To investigate the effect of Genistein on migration of human endothelial cells ECV-304 induced by human ovarian serous cystadenocarcinoma cell line SKOV_3 , and to explore the mechanism of anti-angiogenesis of Genistein .

  24. 人卵巢浆液性乳头状囊腺癌相关基因表达谱

    The Gene Expressive Profile in Human Ovarian Papillary Serous Cystadenocarcinoma

  25. 增殖细胞核抗原表达与卵巢浆液性乳头状囊腺癌预后的关系

    Expression of proliferating cell nuclear antigen ( PCNA ) in ovarian serous cystadenocarcinoma and its relation to prognosis

  26. 结果卵巢透明细胞癌早期患者所占比例为144%,浆液性乳头状囊腺癌为38%,两者比较,差异有极显著性(P<0005)。

    Results The percentage of early stage patients in the clear cell carcinoma of the ovary and the serous adenocarcinoma of the ovary was 14 4 % and 3 8 % respectively , the difference was significant ( P < 0 005 ) .

  27. 目的:探讨DNA拓扑异构酶在卵巢浆液性、黏液性囊腺癌中的表达及与细胞增殖、凋亡的关系。

    Purpose To investigate the relationship between DNA topoisomerase and cell proliferation , apoptosis in ovarian carcinomas .

  28. 结果:(1)宫颈鳞癌、卵巢常见恶性肿瘤(浆液性及粘液性囊腺癌)、滤泡性淋巴瘤的DNA含量和超二倍体率均显著高于相应起源组织或良性肿瘤;

    Results : ( 1 ) DNA contents and the ratio of hyperdiploid were higher in cervical squamous carcinoma , serous and mucinous ovarian cystadenocarcinoma and follicular lymphoma than those of their corresponding original tissues or benign lesions .

  29. 结果:浆液性囊腺瘤凋亡率为10%以下,浆液性囊腺癌凋亡率为38%,凋亡细胞呈灶状分布,无规律性。

    Results : Apoptosis rate of serous cystadenoma was less 10 % and that of serous cystadenocarcinoma was 38 % , cells of programmed death were distributed as plaques , irregularly .

  30. 结果38例中,浆液性囊腺瘤5例,粘液性囊腺瘤3例,浆液性囊腺癌19例,粘液性囊腺癌11例;

    Results 5 patients were serous cystadenoma , 3 patients were mucinous cystadenoma , 19 patients were serous cystadenocarcinoma , 11 patients were cystadenocarcinoma .